Peter F.A. Mulders
Impact in
- Pulmonary and Respiratory Medicine top 0.05%
- Renal cell carcinoma treatment
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics
- Cancer, Lipids, and Metabolism
Papers in
-
- Renal cell carcinoma treatment 103
- Prostate Cancer Treatment and Research 26
- Prostate Cancer Diagnosis and Treatment 14
-
- Cancer Genomics and Diagnostics 14
- Co-authors
- Börje Ljungberg (9 shared papers)Axel S. Merseburger (6 shared papers)Markus Antonius Kuczyk (6 shared papers)Milan Hora (4 shared papers)Egbert Oosterwijk (49 shared papers)Axel Bex (13 shared papers)Cora Nanette Sternberg (7 shared papers)Damian C. Hanbury (3 shared papers)
- Journals
- European Urology (38 papers)The Journal of Urology (13 papers)British Journal of Urology (8 papers)Journal of Nuclear Medicine (7 papers)European Journal of Cancer (6 papers)
- Partner nations
- NetherlandsUnited StatesFrance
In The Last Decade
Peter F.A. Mulders
188 papers receiving 20.9k citations
Peter F.A. Mulders's Hit Papers
Peers
Comparison fields: 5 of 138
- Pulmonary and Respiratory Medicine 14.5k
- Cancer Research 3.5k
- Oncology 3.2k
- Radiology, Nuclear Medicine and Imaging 2.1k
- Molecular Biology 5.8k
Countries citing papers authored by Peter F.A. Mulders
This map shows the geographic impact of Peter F.A. Mulders's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter F.A. Mulders with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter F.A. Mulders more than expected).
Fields of papers citing papers by Peter F.A. Mulders
This network shows the impact of papers produced by Peter F.A. Mulders. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter F.A. Mulders. The network helps show where Peter F.A. Mulders may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter F.A. Mulders, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 190 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy Hit paper breakdown → | 2012 | 3725 |
| 2 | Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy Hit paper breakdown → | 2012 | 2299 |
| 3 | EAU Guidelines on Renal Cell Carcinoma: 2014 Update Hit paper breakdown → | 2015 | 2278 |
| 4 | EAU Guidelines on Renal Cell Carcinoma: The 2010 Update Hit paper breakdown → | 2010 | 1067 |
| 5 | Prognostic Value of Histologic Subtypes in Renal Cell Carcinoma: A Multicenter Experience Hit paper breakdown → | 2005 | 595 |
| 6 | Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour Biopsy Hit paper breakdown → | 2015 | 432 |
| 7 | Multi-Institutional Validation of a New Renal Cancer–Specific Survival Nomogram Hit paper breakdown → | 2007 | 431 |
| 8 | Renal Cell Carcinoma Guideline Hit paper breakdown → | 2007 | 428 |
| 9 | 2004 | 421 | |
| 10 | Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients With Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib Hit paper breakdown → | 2018 | 367 |
| 11 | Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Extended Analysis of the Phase 3 PREVAIL Study Hit paper breakdown → | 2016 | 341 |
| 12 | 2004 | 324 | |
| 13 | Guidelines on Renal Cell Carcinoma | 2007 | 312 |
| 14 | 2016 | 290 | |
| 15 | 2012 | 285 | |
| 16 | 2012 | 242 | |
| 17 | 1995 | 199 | |
| 18 | 2008 | 194 | |
| 19 | 2010 | 194 | |
| 20 | 2012 | 184 |
About Peter F.A. Mulders
Peter F.A. Mulders is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 190 papers that have together received 21.3k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (103 papers), Renal and related cancers (31 papers), Prostate Cancer Treatment and Research (26 papers), Cancer Genomics and Diagnostics (14 papers), Prostate Cancer Diagnosis and Treatment (14 papers), Bladder and Urothelial Cancer Treatments (14 papers), Cancer Immunotherapy and Biomarkers (11 papers) and Immunotherapy and Immune Responses (11 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (14.5k citations), Cancer Research (3.5k citations), Oncology (3.2k citations), Radiology, Nuclear Medicine and Imaging (2.1k citations) and Molecular Biology (5.8k citations). Peter F.A. Mulders has collaborated with scholars based in Netherlands, United States and France. Frequent co-authors include Börje Ljungberg, Axel S. Merseburger, Markus Antonius Kuczyk, Milan Hora, Egbert Oosterwijk, Axel Bex, Cora Nanette Sternberg, Damian C. Hanbury, Ioanel C. Sinescu and Thomas Powles. Their work appears in journals such as European Urology, The Journal of Urology, British Journal of Urology, Journal of Nuclear Medicine and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.